Acelyrin, Inc. (NASDAQ: SLRN)
$2.0300
-0.0700 ( -5.58% ) 549.0K
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.